首页 > 市场调查报告书 > 医疗设备

导管

肿瘤消融市场规模、份额和成长分析（按最终用户、应用和地区划分）—2026-2033年产业预测

市场调查报告书

商品编码

1900234

肿瘤消融市场规模、份额和成长分析（按最终用户、应用和地区划分）—2026-2033年产业预测

Tumor Ablation Market Size, Share, and Growth Analysis, By End User (Hospitals & Clinics, Cancer Care CentersRadiofrequency Ablation), By Application (Kidney Cancer, Liver Cancer), By Region -Industry Forecast 2026-2033

出版日期: 2025年12月26日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，肿瘤消融市场规模将达到 21.7 亿美元，到 2025 年将达到 24.8 亿美元，到 2033 年将达到 71.7 亿美元，在预测期（2026-2033 年）内，复合年增长率为 14.2%。

全球癌症发生率的不断攀升，以及微创治疗方法的日益增多，正推动肿瘤消融手术的需求成长。消融技术的创新为医疗服务提供者开闢了新的可能性，而门诊治疗的日益普及和联合治疗的广泛应用，预计将进一步促进肿瘤消融产品市场的扩张。对先进癌症治疗的需求不断增长，以及肿瘤学研究投入的增加，也为该领域创造了更多商机。中低收入国家癌症病例的快速成长蕴藏着巨大的市场潜力。然而，设备成本高昂、传统治疗方法的竞争以及发展中地区认知度不足等挑战，可能会阻碍市场的长期成长。

肿瘤消融市场驱动因素

全球癌症发生率的不断攀升是肿瘤消融手术需求日益增长的主要原因。这种微创治疗方法正逐渐成为治疗肝癌、肺癌和肾臟癌的首选方法，尤其适用于不适合传统手术的患者。随着癌症发生率的持续上升，对肿瘤消融等高效能微创治疗方法的需求变得更加迫切，市场潜力也随之成长。肿瘤消融能够提供标靶治疗并缩短恢復期，使其成为医护人员和患者都极具吸引力的选择。

限制肿瘤消融市场发展的因素

由于技术先进的肿瘤消融设备高成本，肿瘤消融市场面临严峻的挑战。这些高昂的价格增加了治疗的总成本，使得预算紧张的医疗机构难以购买和运作这些关键设备。因此，肿瘤消融设备的经济负担构成了一大障碍，限制了市场成长和在各类医疗机构中的普及。这种经济限制从根本上影响了医疗服务提供者提供创新治疗方案的能力，并最终阻碍了肿瘤消融市场的发展。

肿瘤消融市场趋势

在肿瘤消融市场，先进影像导引技术的整合正日益成为主流趋势。这些技术能够提高手术精准度，改善患者预后。即时成像技术，例如磁振造影（MRI）、电脑断层扫描（CT）和超音波，正变得至关重要。这些技术使临床医生能够精确定位肿瘤，从而最大限度地减少併发症，提高消融手术的成功率。随着微创治疗需求的不断增长，预计该领域的公司将优先发展成像技术，这将最终改变患者照护，并巩固其在不断发展的癌症治疗领域的竞争优势。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Medtronic plc（Ireland）
Boston Scientific Corporation（USA）
Johnson & Johnson（USA）
Abbott Laboratories（USA）
Varian Medical Systems, Inc.（USA）
Olympus Corporation（Japan）
AngioDynamics, Inc.（USA）
Terumo Corporation（Japan）
Siemens Healthineers AG（Germany）
Merit Medical Systems, Inc.（USA）
EDAP TMS SA（France）
Stryker Corporation（USA）
Hologic, Inc.（USA）
IceCure Medical Ltd.（Israel）
Galil Medical, Inc.（USA）
ConMed Corporation（USA）
Neuwave Medical, Inc.（USA）
SonaCare Medical LLC.（USA）
Mermaid Medical A/S（Denmark）

结论与建议

简介目录

Product Code: SQMIG35A2494

Tumor Ablation Market size was valued at USD 2.17 Billion in 2024 and is poised to grow from USD 2.48 Billion in 2025 to USD 7.17 Billion by 2033, growing at a CAGR of 14.2% during the forecast period (2026-2033).

The increasing global prevalence of cancer, combined with a growing preference for minimally invasive treatment options, is driving demand for tumor ablation procedures. Innovations in ablation technologies are set to unlock new avenues for providers, while the rising trend of utilizing outpatient facilities and the popularity of combination therapies will likely enhance the market for tumor ablation products. The escalating demand for advanced cancer treatments and heightened investments in oncology research are creating further business opportunities within this sector. Low to middle-income countries present significant potential due to a rapid uptick in cancer cases. However, challenges such as high equipment costs, competition from traditional treatments, and limited awareness in developing regions may hinder long-term market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Tumor Ablation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Tumor Ablation Market Segments Analysis

Global Tumor Ablation Market is segmented by Technology, Treatment, Application, End User and region. Based on Technology, the market is segmented into Radiofrequency, Microwave, Irreversible Electroporation and Cryoablation. Based on Treatment, the market is segmented into Surgical Ablation, Percutaneous Ablation and Laparoscopic Ablation. Based on Application, the market is segmented into Lung Cancer, Kidney Cancer and Liver Cancer. Based on End User, the market is segmented into Hospitals and Clinics and Specialty Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Tumor Ablation Market

The rising global prevalence of cancer significantly contributes to the growing demand for tumor ablation procedures. This minimally invasive treatment is increasingly favored for managing liver, lung, and kidney cancers, particularly among patients who are not candidates for traditional surgical options. As the incidence of cancer continues to escalate, the need for effective and less invasive treatment alternatives like tumor ablation becomes even more critical, thereby boosting its market potential. The ability to provide targeted therapy with reduced recovery time makes tumor ablation an attractive option for both medical professionals and patients alike.

Restraints in the Tumor Ablation Market

The tumor ablation market faces significant challenges due to the high costs associated with tumor ablation equipment, which typically employs advanced technologies. These elevated prices contribute to the overall expense of treatment, making it difficult for healthcare facilities with constrained budgets to access and implement these essential tools. As a result, the financial burden of tumor ablation devices serves as a considerable barrier, limiting market growth and accessibility for various healthcare settings. This economic constraint fundamentally impacts the ability of providers to offer innovative treatment options, ultimately hindering advancements in the tumor ablation market.

Market Trends of the Tumor Ablation Market

The tumor ablation market is increasingly trending towards the integration of advanced imaging guidance technologies, which enhance procedural accuracy and improve patient outcomes. The utilization of real-time imaging modalities such as MRI, CT, and ultrasound is becoming essential, as these technologies enable clinicians to visualize tumor locations with precision, thereby minimizing complications and elevating success rates in ablation procedures. As the demand for minimally invasive treatments rises, companies in the sector are expected to prioritize research and development in imaging technologies, ultimately transforming patient care and solidifying their competitive edge in the evolving landscape of cancer treatment.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Tumor Ablation Market Size by Technology & CAGR (2026-2033)

Market Overview
Radiofrequency
Microwave
Irreversible Electroporation
Cryoablation

Global Tumor Ablation Market Size by Treatment & CAGR (2026-2033)

Market Overview
Surgical Ablation
Percutaneous Ablation
Laparoscopic Ablation

Global Tumor Ablation Market Size by Application & CAGR (2026-2033)

Market Overview
Lung Cancer
Kidney Cancer
Liver Cancer

Global Tumor Ablation Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals and Clinics
Specialty Centers

Global Tumor Ablation Market Size & CAGR (2026-2033)

North America (Technology, Treatment, Application, End User)
- US
- Canada
Europe (Technology, Treatment, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Technology, Treatment, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Technology, Treatment, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Technology, Treatment, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Varian Medical Systems, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AngioDynamics, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merit Medical Systems, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EDAP TMS S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IceCure Medical Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Galil Medical, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ConMed Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neuwave Medical, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SonaCare Medical LLC. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mermaid Medical A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments